18/09/2026
FSSAI has initiated three separate adjudication cases against Nestlé India involving infant nutrition products. The regulator flagged certain promotional claims on NAN Excella Pro Stage 1 and Lactogen Pro 1, while a separate laboratory test found a follow-up formula non-conforming for its prescribed biotin content.
Nestlé India has disputed the concerns and said its products and labels comply with applicable regulations.